protein
| ASC ( |
|
ASC, CARD-containing protein Cardinal, and caspase-1 |
|
nucleotide-binding oligomerization domain containing 2, NOD2 |
|
PYCARD connects pathogen/danger sensors such as NLRP3 and NLRC4 with caspases and is involved in inflammation and cell death |
|
CASP1 interacting with PYCARD, AIM2 and NLRP3 (PYCARD inflammasomes, including AIM2 and NLRP3, are critical for CASP1 activation induced by S. pneumoniae) |
|
GBP5 promoted selective NLRP3 inflammasome responses to pathogenic bacteria and soluble but not crystalline inflammasome priming agents |
|
endogenous non-coding RNA-induced NLRP3 inflammasome activation results from DICER1 deficiency in a non-immune cell |
|
DDIT3, a protein known to regulate Ca2+ release from the ER during ER stress, amplifies NLRP3 inflammasome activation |
|
Ca2+ signaling critically regulates NLRP3 inflammasome activation by triggering mitochondrial damage |
|
EIF2AK2 physically interacts with multiple inflammasome components, including NLR family pyrin domain-containing 3 (NLRP3) |
|
PYCARD interacts with NLRP3 via a homotypic PYD interaction and recruits procaspase-1 via a homotypic caspase recruitment domain interaction |
|
is a key component of one of several distinct cytoplasmic multiprotein complexes (inflammasomes) that mediate the maturation of the proinflammatory cytokine IL1B by activating CASP1 |
|
recognition of extracellular Ca2+ through CASR activates the NLRP3 inflammasome |
|
BRCC3, is a critical regulator of NLRP3 activity by promoting its deubiquitination |
|
TRPM2 is a key factor that links oxidative stress to the NLRP3 inflammasome activation |
|
DHX33 is a cytosolic RNA sensor that activates the NLRP3 inflammasome |
|
mitochondria play a critical role in the activation of the NLRP3 inflammasome through the direct binding of NLRP3 to cardiolipin |
|
ATG7-induced CTSB overexpression contributes to an NLRP3-dependent proinflammatory response and subsequently impairs glucose-stimulated insulin secretion (GSIS) independently of apoptosis |
|
MAVS facilitates the recruitment of NLRP3 to the mitochondria and may enhance its oligomerization and activation by bringing it in close proximity to mitochondrial reactive oxygen species |
|
MFN2 is required for the full activation of the NLRP3 inflammasomes in macrophages |
|
NLRP3 inflammasome activates CASP1, which cleaves pro–IL1B to mature forms and stimulates their secretion |
|
lactate negatively regulates TLR induction of the NLRP3 inflammasome and production of IL1B, via ARRB2 and HCAR1 |
|
ubiquitination of DHX33 by TRIM33 is lysine 63 specific and is required for the formation of the DHX33-NLRP3 inflammasome complex |
|
is a transcriptional target of NR1I2 (NR1I2 regulates innate immunity via activation of NLRP3 inflammasome in vascular endothelial cells) |
|
GPSM3 acts as a direct negative regulator of NLRP3 function |
|
ARRB1 plays a critical role in the assembly and activation of two major canonical inflammasomes, NLRC4, NLRP3 |
|
BTK physically interacts with PYCARD and NLRP3 |
|
CASP4 mediates non-canonical activation of the NLRP3 inflammasome in human myeloid cells |
|
PLIN2 inhibits insulin& |
|
8209;induced glucose uptake by activating NLRP3, CASP1 and IL1B, leading to a decreased IRS1 expression |
|
LRRFIP2 and FLII is required for the co-localization of the NLRP3 and F-actin as well as for the inhibition of NLRP3 inflammasome activity |
|
TRIM31 is a feedback suppressor of NLRP3 inflammasome |
|
bile acids and NR1H4 play pivotal roles in sepsis via controlling the NLRP3 inflammasome |
|
endogenous NLRC3 interacts with both PYCARD and pro-caspase-1 but not with NLRP3, disrupts PYCARD speck formation through its CARD, and impairs the PYCARD and pro-caspase-1 interaction |
|
CXCL1 and CXCL2 regulate NLRP3 inflammasome activation via G-Protein-Coupled Receptor CXCR2 |
|
MAP3K5, MAP3K6 was required for NLRP3 up-regulation after lipopolysaccharide treatment in primary bone marrow-derived macrophages and lung fibroblasts as well as during infection with Burkholderia thailandensis and influenza virus |
|
HSPD1 further activates NLRP3 inflammasome by elevating NLRP3 expression both at RNA and protein levels |
|
STAMBP is a negative regulator of the NLRP3 inflammasome |
|
non-degradative ubiquitination of NLRP3 by STAMBP to limit excessive inflammasome activation and to reduce injurious IL1B signaling |
|
TRIM28 binds NLRP3, promotes SUMO1, SUMO2 and SUMO3 modification of NLRP3, and thereby inhibits NLRP3 ubiquitination and proteasomal degradation |